According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

Chronic Pulmonary Aspergillosis is a silent but severe threat to individuals with lung diseases making it important to ...

Discover how metabolic syndrome raises COPD risk in young adults. Learn about the study linking MetS components to ...

Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) shares fell 8% during trading on Tuesday . The stock traded as low as $7.41 and last traded at $7.41. 2,050 shares were traded during trading, ...

Durable and attractive, engineered stone countertops are a popular feature in modern American kitchens, but the workers who ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or ...

Second-hand smoke contains over 7,000 chemicals that can increase the risk of your kid developing allergies, repeated coughs ...

UK resident Patricia Bunting, 76, is currently bedridden and unresponsive in a critical care unit in Florida after ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...